JPH0219117B2 - - Google Patents
Info
- Publication number
- JPH0219117B2 JPH0219117B2 JP57084459A JP8445982A JPH0219117B2 JP H0219117 B2 JPH0219117 B2 JP H0219117B2 JP 57084459 A JP57084459 A JP 57084459A JP 8445982 A JP8445982 A JP 8445982A JP H0219117 B2 JPH0219117 B2 JP H0219117B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- general formula
- alkyl group
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- MHWONQZFFQUJCF-UHFFFAOYSA-N 3-ethenylindolizine Chemical class C1=CC=CN2C(C=C)=CC=C21 MHWONQZFFQUJCF-UHFFFAOYSA-N 0.000 claims description 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 5
- 125000004414 alkyl thio group Chemical group 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- -1 methylthio, ethylthio, propylthio Chemical group 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 150000004820 halides Chemical class 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 229940125782 compound 2 Drugs 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- JWYQUKAMQYWZQU-UHFFFAOYSA-M ethyl 2-(2-benzylpyridin-1-ium-1-yl)acetate;bromide Chemical compound [Br-].CCOC(=O)C[N+]1=CC=CC=C1CC1=CC=CC=C1 JWYQUKAMQYWZQU-UHFFFAOYSA-M 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- CUQOHAYJWVTKDE-UHFFFAOYSA-N potassium;butan-1-olate Chemical compound [K+].CCCC[O-] CUQOHAYJWVTKDE-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- GYBMSOFSBPZKCX-UHFFFAOYSA-N sodium;ethanol;ethanolate Chemical compound [Na+].CCO.CC[O-] GYBMSOFSBPZKCX-UHFFFAOYSA-N 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は下記一般式(1)で示される新規な3−ビ
ニルインドリジン誘導体に関する。
(式中Rは水素原子、低級アルキル基又はフエ
ニル基を、R1は水素原子又は低級アルキル基を、
R2は水素原子又は低級アルキルチオ基を、R3及
びR4はシアノ基、低級アルカノイル基又は低級
アルコキシカルボニル基を、R5は置換基として
低級アルコキシカルボニル基若しくはフエニル基
を有する低級アルキル基、低級アルカノイル基又
はベンゾイル基を意味する)
本発明において定義される低級アルキル基とし
てはメチル、エチル、プロピル、ブチル基等の炭
素数1〜4のアルキル基が、低級アルキルチオ基
としてはメチルチオ、エチルチオ、プロピルチ
オ、ブチルチオ基等の炭素数1〜4のアルキルチ
オ基が、低級アルコキシカルボニル基としてはメ
トキシカルボニル、エトキシカルボニル、プロポ
キシカルボニル、ブトキシカルボニル基等の炭素
数2〜5のアルコキシカルボニル基が、低級アル
カノイル基としてはアセチル、プロパノイル、ブ
タノイル、ペンタノイル基等の炭素数2〜5のア
ルカノイル基が挙げられる。
上記一般式(1)で示される本発明化合物は血小板
擬集抑制作用、抗炎症作用、抗アレルギー作用、
抗菌作用等を有し医薬として有用である。
以下に本発明化合物の製法について説明する。
本発明化合物は例えば一般式(2)で示されるピリジ
ニウム化合物に塩基を作用させ、次いで一般式(4)
で示されるオレフイン化合物を反応させると共に
一般式(5)で示されるハロゲン化物を反応させるこ
とにより製造される。
〈反応工程式〉
(各式中R及びR1〜R5は前記に同じであり、
R6は低級アルキル基を、R7は低級アルコキシ基
又は低級アルキルチオ基を、X及びYはハロゲン
原子を意味する)
上式において原料として使用されるビリジニウ
ム化合物2は公知の化合物であり、例えばジヤー
ナル・オブ・オーガニツク・ケミストリー(J.
Org.Chem)36、2451(1971)に記載の方法又は
これに準ずる方法により容易に合成することがで
きる。塩基としては例えば水酸化ナトリウム、水
酸化カリウム等の水酸化アルカリ金属、水酸化カ
ルシウム、水酸化マグネシウム等の水酸化アルカ
リ土類金属、炭酸水素ナトリウム、炭酸水素カリ
ウム等の炭酸水素アルカリ金属、炭酸ナトリウ
ム、炭酸カリウム等の炭酸アルカリ金属、炭酸カ
ルシウム、炭酸マグネシウム等の炭酸アルカリ土
類金属、ナトリウムメトキシド、ナトリウムエト
キシド、カリウムブトキシド等の金属アルコキシ
ド等の無機塩基、ピリジン、ピコリン、トリエチ
ルアミン、N−メチルピペリジン等の有機塩基が
挙げられる。塩基の使用量は適宜選択することが
できるが、一般にピリジニウム化合物2に対して
約1〜2倍当量程度使用するのが有利である。ビ
リジニウム化合物2と塩基との反応は通常溶媒中
で行われる。溶媒としては反応に不活性な溶媒で
あれば特に限定されないが、例えばメタノール、
エタノール、プロパノール等の低級アルコール
類、エーテル、テトラヒドロフラン、ジオキサン
等のエーテル等、ベンゼン、トルエン、キシレン
等の芳香族炭化水素類、クロロホルム、塩化メチ
レン、四塩化炭素等のハロゲン化炭化水素類、ジ
メチルスルホキシド、ジメチルホルムアミド等の
非プロトン性極性溶媒等の中から使用するビリジ
ニウム化合物2及び塩基の種類により適宜選択し
て使用される。反応温度は特に限定されないが、
通常−20〜150℃付近で行うと反応は有利に進行
する。
上記の反応により一般式(3)で示されるジヒドロ
インドリジン−2−オン化合物が生成する。これ
は通常の方法により反応系より単離可能である
が、本発明では特にこのジヒドロインドリジン−
2−オン化合物3を単離することなく引き続き反
応系内に一般式(4)で示されるオレフイン化合物及
び一般式(5)で示されるハロゲン化物を導入して反
応させることができる。オレフイン化合物4及び
ハロゲン化物5の使用量は適宜選択することがで
きるが、通常ビリジニウム化合物2に対してそれ
ぞれ約1〜5倍モル程度とするのが有利である。
反応温度は特に限定されないが一般に室温〜150
℃程度で行うのが有利である。本反応で生成する
3−ビニルインドリジン誘導体1は通常の分離手
段、例えば再結晶、カラムクロマトグラフイー等
により容易に単離可能である。
本発明の一般式(1)で示される3−ビニルインド
リジン誘導体において、R5が低級アルキル基で
ある化合物については、以下に示す如くハロゲン
化物5に代えて一般式(6)で示される化合物を反応
させることによつても製造することができる。
(式中R,R1〜R4,R6〜R7及びXは前記に同
じであり、R5′は低級アルキル基を意味する)
又、本発明の一般式(1)で示される3−ビニルイ
ンドリジン誘導体は以下に示す如くハロゲン化物
5に代えて一般式(7)で示される化合物を反応させ
ることによつても製造することができる。
(式中R,R1〜R4,R6〜R7及びXは前記に同
じであり、R5″は低級アルカノイル基又はベンゾ
イル基を意味する)
以下本発明の一般式(1)で示される3−ビニルイ
ンドリジン誘導体の代表例を挙げ、次いで各化合
物の製造例を実施例として挙げる。
The present invention relates to a novel 3-vinylindolizine derivative represented by the following general formula (1). (In the formula, R is a hydrogen atom, a lower alkyl group, or a phenyl group, R 1 is a hydrogen atom or a lower alkyl group,
R 2 is a hydrogen atom or a lower alkylthio group, R 3 and R 4 are a cyano group, lower alkanoyl group or lower alkoxycarbonyl group, R 5 is a lower alkyl group having a lower alkoxycarbonyl group or phenyl group as a substituent, lower The lower alkyl group defined in the present invention is an alkyl group having 1 to 4 carbon atoms such as methyl, ethyl, propyl, butyl group, and the lower alkylthio group is methylthio, ethylthio, propylthio. , an alkylthio group having 1 to 4 carbon atoms such as butylthio group, an alkoxycarbonyl group having 2 to 5 carbon atoms such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, butoxycarbonyl group as a lower alkanoyl group, Examples include alkanoyl groups having 2 to 5 carbon atoms such as acetyl, propanoyl, butanoyl, and pentanoyl groups. The compound of the present invention represented by the above general formula (1) has platelet aggregation inhibiting action, anti-inflammatory action, anti-allergic action,
It has antibacterial effects and is useful as a medicine. The method for producing the compound of the present invention will be explained below.
The compound of the present invention can be prepared by, for example, reacting a base with a pyridinium compound represented by the general formula (2), and then forming the pyridinium compound represented by the general formula (4).
It is produced by reacting an olefin compound represented by formula (5) with a halide represented by general formula (5). <Reaction process formula> (In each formula, R and R 1 to R 5 are the same as above,
(R 6 is a lower alkyl group, R 7 is a lower alkoxy group or a lower alkylthio group, and X and Y are halogen atoms.) The viridinium compound 2 used as a raw material in the above formula is a known compound, such as a journal.・Of Organic Chemistry (J.
Org. Chem) 36 , 2451 (1971) or a similar method. Examples of bases include alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, alkaline earth metal hydroxides such as calcium hydroxide and magnesium hydroxide, alkali metal hydrogencarbonates such as sodium hydrogen carbonate and potassium hydrogen carbonate, and sodium carbonate. , alkali metal carbonates such as potassium carbonate, alkaline earth metal carbonates such as calcium carbonate and magnesium carbonate, inorganic bases such as metal alkoxides such as sodium methoxide, sodium ethoxide and potassium butoxide, pyridine, picoline, triethylamine, N-methyl Examples include organic bases such as piperidine. Although the amount of the base to be used can be selected as appropriate, it is generally advantageous to use the base in an amount of about 1 to 2 times the amount of the pyridinium compound 2. The reaction between the viridinium compound 2 and the base is usually carried out in a solvent. The solvent is not particularly limited as long as it is inert to the reaction, but examples include methanol,
Lower alcohols such as ethanol and propanol, ethers such as ether, tetrahydrofuran, and dioxane, aromatic hydrocarbons such as benzene, toluene, and xylene, halogenated hydrocarbons such as chloroform, methylene chloride, and carbon tetrachloride, and dimethyl sulfoxide. , aprotic polar solvents such as dimethylformamide, etc., depending on the type of the viridinium compound 2 and the base used. The reaction temperature is not particularly limited, but
The reaction usually proceeds advantageously when carried out at around -20 to 150°C. The above reaction produces a dihydroindolizin-2-one compound represented by general formula (3). This can be isolated from the reaction system by a conventional method, but in the present invention, this dihydroindolizine-
Without isolating the 2-one compound 3, the olefin compound represented by the general formula (4) and the halide represented by the general formula (5) can be subsequently introduced into the reaction system and reacted. The amounts of the olefin compound 4 and the halide 5 to be used can be selected as appropriate, but it is usually advantageous to use about 1 to 5 times the molar amount of each of the viridinium compounds 2.
The reaction temperature is not particularly limited, but is generally room temperature to 150℃.
It is advantageous to carry out the reaction at a temperature of about 0.degree. The 3-vinylindolizine derivative 1 produced in this reaction can be easily isolated by conventional separation means such as recrystallization, column chromatography, etc. In the 3-vinylindolizine derivatives represented by the general formula (1) of the present invention, for compounds in which R 5 is a lower alkyl group, the compound represented by the general formula (6) is substituted for the halide 5 as shown below. It can also be produced by reacting. (In the formula, R, R 1 to R 4 , R 6 to R 7 and X are the same as above, and R 5 ' means a lower alkyl group) In addition, -Vinyl indolizine derivatives can also be produced by reacting a compound represented by general formula (7) in place of halide 5, as shown below. (In the formula, R, R 1 to R 4 , R 6 to R 7 and X are the same as above, and R 5 ″ means a lower alkanoyl group or a benzoyl group) Representative examples of 3-vinyl indolizine derivatives are listed below, and then production examples of each compound are listed as examples.
【表】【table】
【表】【table】
【表】【table】
【表】【table】
【表】
C H N C H
N
23 71.12 5.19 7.21 71.23 5.14
7.16
24 74.30 4.62 6.42 74.39 4.63
6.32
25 68.89 5.30 6.69 68.90 5.31
6.67
26 67.54 4.05 11.25 67.55 4.16 1
1.28
実施例 1
2−ベンジル−1−(エトキシカルボニルメチ
ル)ピリジニウムブロミド1.008g(3ミリモル)
を含むエタノール溶液60mlにナトリウムエトキシ
ドエタノール溶液6ml(6ミリモルのナトリウム
エトキシドを含む)を加え、60〜80℃に3分間反
応させた後、α−シアノ−β−エトキシ−アクリ
ル酸エチル0.507g(3ミリモル)を加える。こ
のまま1分間反応させた後、無水酢酸2mlを加え
5分間反応させる。反応混合物を減圧濃縮し残渣
をエーテル−クロロホルムを用いてアルミナカラ
ムで分離した後、エタノールから再結晶して2−
アセトキシ−3−(2−シアノ−2−エトキシカ
ルボニルビニル)−1−フエニルインドリジン
(化合物No.19)を得た。
実施例1と同様の方法により、他の化合物を合
成した。[Table] C H N C H
N
23 71.12 5.19 7.21 71.23 5.14
7.16
24 74.30 4.62 6.42 74.39 4.63
6.32
25 68.89 5.30 6.69 68.90 5.31
6.67
26 67.54 4.05 11.25 67.55 4.16 1
1.28
Example 1 2-benzyl-1-(ethoxycarbonylmethyl)pyridinium bromide 1.008 g (3 mmol)
60 ml of sodium ethoxide ethanol solution (containing 6 mmol of sodium ethoxide) was added to 60 ml of ethanol solution containing sodium ethoxide, and after reacting at 60 to 80°C for 3 minutes, 0.507 g of ethyl α-cyano-β-ethoxy-acrylate (3 mmol) is added. After reacting for 1 minute, add 2 ml of acetic anhydride and react for 5 minutes. The reaction mixture was concentrated under reduced pressure, the residue was separated on an alumina column using ether-chloroform, and then recrystallized from ethanol to give 2-
Acetoxy-3-(2-cyano-2-ethoxycarbonylvinyl)-1-phenylindolizine (Compound No. 19) was obtained. Other compounds were synthesized in the same manner as in Example 1.
Claims (1)
ニル基を、R1は水素原子又は低級アルキル基を、
R2は水素原子又は低級アルキルチオ基を、R3及
びR4はシアノ基、低級アルカノイル基又は低級
アルコキシカルボニル基を、R5は置換基として
低級アルコキシカルボニル基若しくはフエニル基
を有する低級アルキル基、低級アルカノイル基又
はベンゾイル基を意味する)で示される3−ビニ
ルインドリジン誘導体。[Claims] 1. General formula (In the formula, R is a hydrogen atom, a lower alkyl group, or a phenyl group, R 1 is a hydrogen atom or a lower alkyl group,
R 2 is a hydrogen atom or a lower alkylthio group, R 3 and R 4 are a cyano group, lower alkanoyl group or lower alkoxycarbonyl group, R 5 is a lower alkyl group having a lower alkoxycarbonyl group or phenyl group as a substituent, lower A 3-vinylindolizine derivative represented by an alkanoyl group or a benzoyl group.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57084459A JPS58201780A (en) | 1982-05-18 | 1982-05-18 | 3-vinylindolizine derivative and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57084459A JPS58201780A (en) | 1982-05-18 | 1982-05-18 | 3-vinylindolizine derivative and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58201780A JPS58201780A (en) | 1983-11-24 |
JPH0219117B2 true JPH0219117B2 (en) | 1990-04-27 |
Family
ID=13831205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57084459A Granted JPS58201780A (en) | 1982-05-18 | 1982-05-18 | 3-vinylindolizine derivative and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58201780A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5112833A (en) * | 1988-12-26 | 1992-05-12 | Zenyaku Kogyo Kabushiki Kaisha | 1-azaindolizine derivatives, synthetic intermediates thereof and antiallergic agents containing 1-azaindolizine derivatives |
JP2008101064A (en) * | 2006-10-17 | 2008-05-01 | Tdk Corp | Dye, electrode and photoelectric conversion element |
-
1982
- 1982-05-18 JP JP57084459A patent/JPS58201780A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS58201780A (en) | 1983-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2556722B2 (en) | Novel sulfonamide compound | |
CN108794412B (en) | Preparation method of 4, 5-diaryl-2H-1, 2, 3-triazole compound | |
JP2731853B2 (en) | Method for producing tri-lower alkanoyloxyboron | |
JPH0219117B2 (en) | ||
JPS58164577A (en) | 4-benzyl-1-(2h)isoquinolone derivative and preparation thereof | |
IL28645A (en) | Tropine derivatives | |
US4115642A (en) | Method for preparing auranofin | |
JP2002105058A (en) | Method for manufacturing 1,3-dialkylimidazolium iodide salt | |
CA1137482A (en) | Process for the production of 5-aminoisoxazoles | |
JPH11130752A (en) | Production of heteroaryl carboxylic amide and ester | |
EP1471058B1 (en) | Process for producing 1,2,3-triazole compound | |
JPH0217549B2 (en) | ||
JP2603108B2 (en) | Anilinopyrimidine derivative | |
KR810000859B1 (en) | Method for preparing derivatives of 7-amino- 3-desacetoxy cephalosporanic acid | |
US4334088A (en) | 2-Alkynyl-5-indanyloxyacetic acids | |
JPH0217550B2 (en) | ||
JPH0220638B2 (en) | ||
US4260544A (en) | Halogenomethylene-indoxyls | |
JPH06228103A (en) | New octahydroacridine derivative and its production | |
KR830000634B1 (en) | How to prepare N-trityl imidazole compound | |
JP3706154B2 (en) | Novel halomethylene compounds or salts thereof | |
JPH0641066A (en) | Production of pyrrole derivative | |
US4569999A (en) | 2-Substituted-3-sulfonamide-pyridine derivatives | |
US4291168A (en) | Silylated indanyloxyacetates | |
KR790001654B1 (en) | Process for the preparation of s-triazolo(3,4-b)benzothiazoles |